Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa.
Increased provision of antiretroviral therapy in sub-Saharan Africa has led to a growing number of patients with therapy failure and acquired drug-resistant HIV, driving the demand for more costly further lines of antiretroviral therapy. In conjunction with accelerated access to viral load monitorin...
Main Authors: | Inzaule, S, Ondoa, P, Peter, T, Mugyenyi, P, Stevens, W, de Wit, T, Hamers, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2016
|
Similar Items
-
The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa
by: Inzaule, SC, et al.
Published: (2020) -
Plasma biomarkers of HIV-related systemic inflammation and immune activation in sub-Saharan Africa before and during suppressive antiretroviral therapy
by: Kroeze, S, et al.
Published: (2019) -
Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa
by: Boender, T, et al.
Published: (2016) -
Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance
by: Inzaule, S, et al.
Published: (2018) -
Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts
by: Bijker, R, et al.
Published: (2017)